IQV
Stock Details
IQV is IQVIA Holdings Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 223.28$. Average daily volumn in 3 months 890.42k. Market cap 35.33B
Stock symbol : IQV. Exchange : NYSE. Currency : USD Lastest price : 189.43$. Total volume : 1.23M. Market state CLOSED Click reload if you want to check the lastest price on market!!!
IQVIA Holdings Inc. (IQV)
Last Price
189.43$Change
-1.19Volume
1.23M
| Previous Close | 190.62 |
| Open | 188.78 |
| Day Range | 186.24-191.21 |
| Bid | 180.63 x 1k |
| Ask | 188.72 x 800 |
| Volume | 1.23M |
| Average Volume | 890.42k |
| Market Cap | 35.33B |
| Beta | 1.35 |
| 52 Week Range | 186.24-285.61 |
| Trailing P/E | 32.72 |
| Foward P/E | 16.54 |
| Dividend (Yield %) | N/A |
| Ex-Dividend Date | N/A |
Financial Details
Organization
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life scienc... es and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Market Cap:
35.33BRevenue:
13.87BTotal Assets:
24.69BTotal Cash:
1.37B
News about "IQVIA Holdings Inc."
Gateway Investment Advisers LLC Has $240,000 Holdings in IQVIA Holdings Inc. (NYSE:IQV)
Source from : Defense World - 12 hours ago
Gateway Investment Advisers LLC increased its stake in IQVIA Holdings Inc. (NYSE:IQV – Get Rating) by 8.3% in the 2nd quarter, according to the company in its most recent 13F filing with the ...See details»
Parkside Financial Bank & Trust Cuts Stock Position in IQVIA Holdings Inc. (NYSE:IQV)
Source from : Defense World - 11 hours ago
Parkside Financial Bank & Trust lowered its stake in IQVIA Holdings Inc. (NYSE:IQV – Get Rating) by 24.0% during the 2nd quarter, according to its most recent filing with the Securities & Exchange ...See details»
IQVIA: Rebound Is Likely But Downtrend Is Still Intact (Technical Analysis)
Source from : Seeking Alpha - 5 days ago
IQVIA bottomed on June 16 and has since rallied 28% in a breakout attempt that finally failed. Click here to read our analysis of the IQV stock.See details»
Here's Why a Hold Strategy is Apt for IQVIA (IQV) Stock
Source from : Nasdaq - 8 days ago
A set of robust capabilities places IQVIA strongly in the life sciences space and positions it well to make the most of the market opportunities. The company has a strong healthcare-specific global IT ...See details»
IQVIA Holdings Inc
Source from : Reuters - 6 days ago
19 Oct 2022 / 12:30 PM UTCQ3 2022 IQVIA Holdings Inc Earnings Release 13 Feb 2023 / 1:30 PM UTCQ4 2022 IQVIA Holdings Inc Earnings Release ...See details»
Bullish insiders bet US$2.7m on IQVIA Holdings Inc. (NYSE:IQV)
Source from : Nasdaq - 1 month ago
Multiple insiders secured a larger position in IQVIA Holdings Inc. (NYSE:IQV) shares over the last 12 months. This is reassuring as this suggests that insiders have increased optimism about the ...See details»
L1 Capital : “IQVIA Holdings (IQV) Expects to Deliver Consistent, Compounding Growth”
Source from : Insider Monkey - 16 days ago
L1 Capital International discussed stocks like IQVIA Holdings Inc. (NYSE:IQV) in the second quarter investor letter. IQVIA Holdings Inc. (NYSE:IQV) is an analytical technology services and ...See details»
IQVIA Holdings Inc BDR (I1QV34)
Source from : Investing - 22 days ago
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...See details»
Expert Ratings for IQVIA Hldgs
Source from : Business Insider - 12 days ago
According to 6 analyst offering 12-month price targets in the last 3 months, IQVIA Hldgs has an average price target of $257.0 with a high of $300.00 and a low of $235.00. Below is a summary of how ...See details»
New York firm tries to squash Iqvia's lawsuit over former VP
Source from : The Business Journals - 9 days ago
Iqvia (NYSE: IQV) filed a complaint June 16 against Buffalo-based Circuit Clinical Solutions for allegedly interfering with an agreement Iqvia had in place with a former employee that restricted ...See details»
IQVIA CEO Ari Bousbib to Speak at Baird Global...
Source from : Benzinga.com - 22 days ago
IQVIA Holdings Inc. ("IQVIA") IQV, announced today that Ari Bousbib, chairman and chief executive officer, will speak at the Baird 2022 Global Healthcare Conference in New York City on Wednesday ...See details»
6 Analysts Have This to Say About IQVIA Hldgs
Source from : Business Insider - 12 days ago
In the last 3 months, 6 analysts have offered 12-month price targets for IQVIA Hldgs. The company has an average price target of $257.0 with a high of $300.00 and a low of $235.00. Below is a summary ...See details»
IQVIA CFO Ron Bruehlman to Speak at Morgan Stanley…
Source from : PharmiWeb - 23 days ago
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the ...See details»
At US$232, Is IQVIA Holdings Inc. (NYSE:IQV) Worth Looking At Closely?
Source from : Yahoo Finance - 1 month ago
IQVIA Holdings Inc. (NYSE:IQV) saw a double-digit share price rise of over 10% in the past couple of months on the NYSE. As a large-cap stock with high coverage by analysts, you could assume any ...See details»